IRulya Therapeutics (IRLA) Common Stock Issued (2019 - 2026)
IRulya Therapeutics' Common Stock Issued came in at $5.35 million for Q2 2026, up 79.2% from $2.99 million a year earlier but down 64.3% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Common Stock Issued (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, IRulya Therapeutics reported Common Stock Issued of $23.75 million, up 672.8% year-over-year; for FY2025, it was $6.48 million.
- Common Stock Issued carries a five-year compound annual growth rate of -44.1% (FY2020 to FY2025).
- Going back by year, Common Stock Issued was $225,000 in FY2024 (+51.0%), $149,000 in FY2023 (-80.3%), $756,000 in FY2022 (-88.9%) and $6.81 million in FY2021 (-94.3%).
- The five-year range for quarterly Common Stock Issued is $10,000 (Q3 2023) to $14.99 million (Q1 2026).
- The fastest year-over-year change in Common Stock Issued over five years came in Q1 2024 (growth of 239.3%), and the weakest in Q3 2022 (a decline of 99.7%).
- Business Quant data shows IRLA's Common Stock Issued at $14.99 million (Q1 2026), $2.03 million (Q4 2025) and $1.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 5.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.35 Mn |
| Mar 31, 2026 | 14.99 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 87,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 190,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 622,000.00 |
| Dec 31, 2021 | 990,000.00 |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 672,000.00 |
| Mar 31, 2021 | 441,000.00 |
| Dec 31, 2020 | 47,000.00 |
API Access
IRulya Therapeutics Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();